Skip to main content

CITIGROUP INC

Position in TVTX — Travere Therapeutics, Inc.

CIK 831001 NEW YORK, NY

Position in TVTX

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$6,535,705
+$5,729,644 QoQ
Shares Held
115,045
+324.0% QoQ
Ownership
0.122%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#95
of 315 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TVTX Over Time

Shares Held

Position Value (USD)

Derivatives in TVTX

reported options exposure · as of Dec 31, 2020
CallValue
$2,725
CallShares
100
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITIGROUP INC holds $2,077,377,990 across 384 Biotechnology names. TVTX ranks #53 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in TVTX

Export CSV
30 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,535,705 115,045
2026-03-31 $806,061 27,131
2025-12-31 $1,035,911 27,111
2025-09-30 $294,470 12,321
2025-06-30 $999,782 67,553
2025-03-31 $3,158,326 176,246
2024-12-31 $2,389,255 137,156
2024-09-30 $805,837 57,601
2024-06-30 $369,512 44,953
2024-03-31 $3,909,223 507,033
2023-12-31 $1,906,444 212,063
2023-09-30 $2,980,336 333,371
2023-06-30 $4,077,496 265,462
2023-03-31 $8,142,976 362,071
2022-12-31 $3,053,724 145,208
2022-09-30 $4,715,701 191,384
2022-06-30 $3,316,941 136,894
2022-03-31 $769,104 29,845
2021-12-31 $4,481,679 144,384
2021-09-30 $5,718,804 235,827
2021-06-30 $3,071,472 210,519
2021-03-31 $3,119,776 124,941
2020-12-31 $2,725 100
2020-12-31 $326,241 11,970
2020-09-30 RTRX 4,600
2020-09-30 RTRX 100
2020-06-30 RTRX 31,814
2020-06-30 RTRX 100
2020-03-31 RTRX 100
2020-03-31 RTRX 34,690